Nyloxin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Nyloxin
Generic name: NAJA NAJA VENOM
Manufacturer: Nutra Pharma Corporation
Product type: HUMAN OTC DRUG
SPL set ID: 0ea98615-f6d3-4f74-8faf-c828b7cfc7d3
SPL ID: bbccd2a6-c675-4b2a-a7cf-36fc46580f56
Version: 5
Effective date: 2025-10-14
Source export date: 2026-11-06
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/2233cb6af8c6b55a5e4a05449e8db0d2f259f3c061d5d001b654a8bea1cc1db2/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:55:05

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Nyloxin	openfda.brand_name
generic name		NAJA NAJA VENOM	openfda.generic_name
manufacturer name		Nutra Pharma Corporation	openfda.manufacturer_name
ndc	package	47219-300-08	openfda.package_ndc
ndc	product	47219-300	openfda.product_ndc
ndc11	package	47219030008	derived:openfda.package_ndc
spl id		bbccd2a6-c675-4b2a-a7cf-36fc46580f56	id
spl set id		0ea98615-f6d3-4f74-8faf-c828b7cfc7d3	set_id
unii		ZZ4AG7L7VM	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: For external use only If symptoms persist or worsen, discontinue use and seek medical attention. Avoid contact with eyes. If product gets into eyes, flush with water. Seek medical attention. Not for use on open wounds. Directions For Use: Remove protective wrapping. Liberally apply gel to the affected area and rub into joints. Use 3-4 times per day for the first week. Use as needed thereafter to relieve discomfort. Allow several days for drug to take maximum effect.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.